All stock lists
Pediatrix Medical Group, Inc. (New York Stock Exchange:MD)
US · Delayed Price · Currency is USD
Healthcare · Medical - Care Facilities
29.43+0.14 (+0.46%)
Insider Score
––Not scored
MD Insider Score
Insiders here have filed 8 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
MD analyst forecast
MD analyst consensus
Hold2 ratings
Buy 0 Hold 2 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
MD 12-month price target
$25.67-11.9% downsideaverage of 3 firms
$28.00High
$24.00Low
Best analysts covering MD
No firm covering MD has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
MD analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Jefferies | Hold | $28.00 | +5.4% | Downgraded | 2026-08-19 | |
| — | UBS | Neutral | — | — | Reiterated | 2026-08-06 |
| Deutsche Bank | — | $25.00 | -4.1% | — | 2026-08-05 | |
| — | Truist Securities | Hold | — | — | Reiterated | 2026-07-14 |
| — | UBS | Neutral | — | — | Reiterated | 2026-05-12 |
| Jefferies | — | $27.00 | +16.3% | — | 2026-04-20 | |
| — | Truist Securities | Hold | — | — | Reiterated | 2026-04-13 |
| — | UBS | Neutral | — | — | Reiterated | 2026-02-24 |
| — | Truist Securities | Hold | — | — | Reiterated | 2026-02-20 |
| — | Truist Securities | Hold | — | — | Reiterated | 2025-11-10 |
| Truist Financial | — | $24.00 | +7.6% | — | 2025-11-10 | |
| — | UBS | Neutral | — | — | Reiterated | 2025-11-05 |
| Truist Financial | — | $17.00 | +6.0% | — | 2025-10-14 | |
| — | Leerink Partners | Market Perform | — | — | Reiterated | 2025-09-05 |
| — | UBS | Neutral | — | — | Reiterated | 2025-08-14 |
| — | UBS | Neutral | — | — | Reiterated | 2025-05-12 |
| — | Macquarie | Outperform | — | — | Reiterated | 2025-05-08 |
| — | Truist Securities | Hold | — | — | Reiterated | 2025-04-11 |
| — | Truist Securities | Hold | — | — | Reiterated | 2025-02-21 |
| — | UBS | Neutral | — | — | Reiterated | 2025-02-21 |
| — | Truist Securities | Hold | — | — | Reiterated | 2025-01-06 |
| — | Mizuho | Neutral | — | — | Reiterated | 2024-11-19 |
| — | UBS | Neutral | — | — | Reiterated | 2024-11-05 |
| — | Jefferies | Buy | — | — | Reiterated | 2024-11-05 |
| — | Deutsche Bank | Hold | — | — | Reiterated | 2024-11-04 |
| — | Truist Securities | Hold | — | — | Reiterated | 2024-11-04 |
| — | Mizuho | Neutral | — | — | Reiterated | 2024-11-04 |
| — | Truist Securities | Hold | — | — | Reiterated | 2024-10-07 |
| Truist Financial | — | $13.00 | +7.2% | — | 2024-10-07 | |
| Jefferies | Buy | $14.00 | +24.3% | Upgraded | 2024-09-26 | |
| — | Truist Securities | Hold | — | — | Reiterated | 2024-08-15 |
| Truist Financial | — | $10.00 | -1.6% | — | 2024-08-15 | |
| — | UBS | Neutral | — | — | Reiterated | 2024-08-09 |
| — | Truist Securities | Hold | — | — | Reiterated | 2024-07-15 |
| Deutsche Bank | Hold | $8.00 | +16.1% | Upgraded | 2024-06-07 | |
| — | Truist Securities | Hold | — | — | Reiterated | 2024-05-15 |
| — | Jefferies | Hold | — | — | Reiterated | 2024-03-06 |
| — | Mizuho | Neutral | — | — | Reiterated | 2024-02-21 |
| — | Truist Securities | Hold | — | — | Reiterated | 2024-02-21 |
| — | Truist Securities | Hold | — | — | Reiterated | 2023-10-11 |
| — | Truist Securities | Hold | — | — | Reiterated | 2023-05-09 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2023-02-22 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2022-12-05 |
| — | Mizuho | Neutral | — | — | Reiterated | 2022-11-16 |
| — | SVB Leerink | Market Perform | — | — | Reiterated | 2022-11-04 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2022-08-11 |
| — | BMO Capital | Market Perform | — | — | Reiterated | 2022-08-10 |
| — | SVB Leerink | Market Perform | — | — | Reiterated | 2022-05-12 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2022-05-03 |
| — | Mizuho | Neutral | — | — | Reiterated | 2022-05-02 |
| — | SVB Leerink | Market Perform | — | — | Reiterated | 2022-04-27 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2022-02-23 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2021-12-22 |
| — | SVB Leerink | Market Perform | — | — | Reiterated | 2021-11-04 |
| — | SVB Leerink | Perform | — | — | Reiterated | 2021-09-27 |
| — | Mizuho | Neutral | — | — | Reiterated | 2021-08-09 |
| — | Citigroup | Neutral | — | — | Reiterated | 2021-05-24 |
| — | Deutsche Bank | Sell | — | — | Reiterated | 2021-05-10 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2021-02-19 |
| — | Deutsche Bank | Sell | — | — | Downgraded | 2020-10-19 |
MD earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-19 | 0.53 | 0.50 | $486.2M | $493.8M |
| 2026-05-05 | 0.37 | 0.44 | $465.8M | $476.2M |
| 2026-08-04 | 0.59 | 0.63 | $478.5M | $487.8M |
| 2026-10-29 | 0.65 | 0.00 | $498.2M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.